Radiation dose showdown: can more radiation save rectums from surgery?

NCT ID NCT04095299

Recruiting now Disease control Sponsor: Vejle Hospital Source: ClinicalTrials.gov ↗

Summary

This study is testing whether a higher dose of radiation, combined with chemotherapy, is better than the standard dose at helping people with early-stage rectal cancer avoid major surgery. The goal is to control the cancer while preserving the rectum, improving quality of life. About 162 patients will be randomly assigned to receive either the standard or the higher radiation dose.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER OF RECTUM are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Aalborg University Hospital
RECRUITING

Aalborg, Denmark
Copenhagen University Hospital, Righshospitalet and Bispebjerg Hospital
RECRUITING

Copenhagen, Denmark
Department of Oncology, Vejle Hospital
RECRUITING

Vejle, Denmark

Contact Email: •••••@•••••
Zealand University Hospital, Næstved
RECRUITING

Næstved, Denmark
Zealand University Hospital, Roskilde
RECRUITING

Roskilde, Denmark

Conditions

Explore the condition pages connected to this study.

CANCER OF RECTUM